Share This

Hot News

藥明生物揭業務轉弱股價急挫停牌昨晚公告:料今年收入仍增10% 今復牌- 20231205 - 經濟 @ 2023-12-05T20: Back Hot News
Keyword:藥明生物
Concept:藥明生物業務
《大行報告》中金下調藥明生物(02269.HK)目標價至57元 評級「跑贏行業」
《大行報告》麥格理降藥明生物(02269.HK)評級至「中性」 目標價下調至38元
《大行報告》野村降藥明生物(02269.HK)目標價至58.23元 料進一步下跌空間有限
大行評級|富瑞:下調藥明生物目標價至69港元 維持「買入」評級
《大行報告》大和降藥明生物(02269.HK)評級至「持有」 目標價削至33元
大行評級|建銀國際:維持藥明生物「跑贏大市」評級 目標價下調至66港元
藍籌生物科技股藥明生物(2269.HK)昨日開市前公布業務更新,預料毛利率與收入增速於今年全年與明年上半年最具挑戰。消息拖累該股裂口低開13%,上午中途停牌,停牌前勁挫23.8%,股份今日復牌。有大行狠劈藥明生物目標價兩成,料到2025年才獲投資者重新吸納。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.